Virtus ETF Advisers’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,016
| Closed | -$316K | – | 487 |
|
|
2024
Q4 | $316K | Buy |
2,016
+214
| +12% | +$33.5K | 0.13% | 238 |
|
|
2024
Q3 | $328K | Hold |
1,802
| – | – | 0.15% | 224 |
|
|
2024
Q2 | $331K | Buy |
1,802
+1,058
| +142% | +$194K | 0.16% | 210 |
|
|
2024
Q1 | $132K | Sell |
744
-52
| -7% | -$9.25K | 0.07% | 340 |
|
|
2023
Q4 | $98.8K | Buy |
796
+30
| +4% | +$3.72K | 0.06% | 365 |
|
|
2023
Q3 | $88.9K | Sell |
766
-74
| -9% | -$8.58K | 0.05% | 350 |
|
|
2023
Q2 | $98.6K | Sell |
840
-466
| -36% | -$54.7K | 0.06% | 390 |
|
|
2023
Q1 | $105K | Sell |
1,306
-498
| -28% | -$39.9K | 0.06% | 333 |
|
|
2022
Q4 | $143K | Sell |
1,804
-267
| -13% | -$21.2K | 0.07% | 357 |
|
|
2022
Q3 | $144K | Buy |
2,071
+16
| +0.8% | +$1.11K | 0.06% | 360 |
|
|
2022
Q2 | $135K | Sell |
2,055
-144
| -7% | -$9.46K | 0.05% | 338 |
|
|
2022
Q1 | $146K | Sell |
2,199
-137
| -6% | -$9.1K | 0.07% | 230 |
|
|
2021
Q4 | $163K | Sell |
2,336
-952
| -29% | -$66.4K | 0.06% | 318 |
|
|
2021
Q3 | $172K | Sell |
3,288
-167
| -5% | -$8.74K | 0.08% | 306 |
|
|
2021
Q2 | $235K | Sell |
3,455
-1,696
| -33% | -$115K | 0.1% | 230 |
|
|
2021
Q1 | $397K | Buy |
5,151
+99
| +2% | +$7.63K | 0.17% | 185 |
|
|
2020
Q4 | $303K | Sell |
5,052
-1,794
| -26% | -$108K | 0.13% | 206 |
|
|
2020
Q3 | $295K | Sell |
6,846
-938
| -12% | -$40.4K | 0.15% | 229 |
|
|
2020
Q2 | $322K | Buy |
7,784
+2,268
| +41% | +$93.8K | 0.15% | 292 |
|
|
2020
Q1 | $239K | Sell |
5,516
-791
| -13% | -$34.3K | 0.1% | 259 |
|
|
2019
Q4 | $349K | Sell |
6,307
-2,976
| -32% | -$165K | 0.06% | 284 |
|
|
2019
Q3 | $322K | Sell |
9,283
-517
| -5% | -$17.9K | 0.06% | 193 |
|
|
2019
Q2 | $395K | Buy |
+9,800
| New | +$395K | 0.08% | 192 |
|